Market Trends Regulus stock tumbles 24% amid study, regulatory updates (RGLS:NASDAQ)By admin8996erT0allJanuary 29, 2025 peterschreiber.media/iStock via Getty ImagesRegulus Therapeutics (NASDAQ:RGLS) shares tumbled 24% Wednesday after the biotech company reported results from a study analysis…